Ποια είναι η τιμή για Molecular Pharmacology (USA), Ltd. (MLPH)

Η τιμή για Molecular Pharmacology (USA), Ltd. (MLPH) είναι $0.0322

Ποια είναι η κεφαλαιοποίηση αγοράς για Molecular Pharmacology (USA), Ltd. (MLPH)

Η κεφαλαιοποίηση αγοράς για Molecular Pharmacology (USA), Ltd. (MLPH) είναι $643.71K

Molecular Pharmacology (USA), Ltd. (MLPH) Κέρδη

As a development-stage company, Molecular Pharmacology (USA) Limited (MLPH) is dedicated to the creation and market introduction of solutions for pain and inflammation, with a primary focus on the Australian and United States markets. Through its subsidiary, Molecular Pharmacology Pty. Ltd., it is advancing an analgesic and anti-inflammatory molecule called Tripeptofen, designed to alleviate common daily pain. These products are offered in diverse dosage forms, formulations, and packaging options to suit various needs. MLPH's marketing strategy involves leveraging pharmaceutical distributors and forging collaborative partnerships with companies in the United States and Europe. Additionally, the company maintains an agreement with Dermatology Development Corporation to jointly develop and market a suite of therapeutic, cosmetic, and cosmeceutical items derived from the ThermaLIFE product line and its core active component. Headquartered in Perth, Australia, Molecular Pharmacology (USA) Limited operates as a subsidiary of PharmaNet Group Limited.

Έτος	Κέρδη	Αλλαγή
Δεν υπάρχουν αρκετά δεδομένα για τις παρεχόμενες ημερομηνίες.

Έτος

Κέρδη

Αλλαγή

Δεν υπάρχουν αρκετά δεδομένα για τις παρεχόμενες ημερομηνίες.

Εταιρεία	Κέρδη	Διαφορά Κερδών	Χώρα
Vertex Pharmaceuticals Incorporated VRTX.US	$5.27B	-	US
Argenx SE ARGX.US	$1.95B	-	NL
Lonza Group AG LONN.SW	-	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR
UCB S.A. UCB.BR	$3.01B	-	BE

Εταιρεία

Κέρδη

Διαφορά Κερδών

Χώρα